SEMA – Semaglutide 2 mg

39,90 

In stock

  • *Quantity in package

SEMA – Semaglutide 2mg are tested and have required amount of substance of highest quality:

» Test results of our Semaglutide 2mg

» Fat loss up to 20% of weight in 68 weeks
» Better insulin sensitivity
» Improves blood pressure and cholesterol

Semaglutide 2 mg is a high-purity lyophilized research peptide supplied in a sterile glass vial containing 2 mg of active compound per unit. Semaglutide is a potent GLP-1 receptor agonist widely studied in metabolic and endocrinology research. This product is intended strictly for laboratory and scientific research use only.

Reconstitute:
Add 1.0 mL bacteriostatic water → 5.0 mg concentration for optimal weekly doses.
Typical weekly range:
0.25-2.5 mg once or twice weekly (gradual escalation over 12+ weeks).
Easy measuring:
At 5.0 mg/mL, 0.25 mg = 0.005 mL ≈ 50mcg on a U-100 insulin syringe.
Storage after reconstitution:
refrigerate at 2-8 °C and use up to 4 weeks.

SKU: SEMA2 Category:

Description

Semaglutide 2 mg is a premium-grade lyophilized investigational peptide supplied in a sterile glass vial containing 2 milligrams per unit. Semaglutide selectively targets the GLP-1 (Glucagon-Like Peptide-1) receptor, which is a key regulator of metabolic signaling pathways.

This peptide is extensively studied in preclinical and research laboratory settings for its effects on glucose metabolism, energy balance, and related endocrine pathways. Semaglutide is intended strictly for laboratory research and scientific investigation and is not approved for human or clinical use.


Mechanism of Action

Semaglutide is engineered to selectively activate GLP-1 receptors, which are involved in:

• Glucose-dependent insulin signaling
• Appetite regulation and satiety research
• Metabolic pathway modulation

This receptor-selective activity makes Semaglutide a widely used tool in laboratory research exploring endocrine and metabolic processes.


Research Applications

Semaglutide 2 mg is commonly used in laboratory research for:

• Glucose metabolism studies
• Insulin sensitivity research
• Appetite and energy balance modeling
• Obesity-related metabolic pathway research
• Endocrinology laboratory experiments
• Receptor binding and signaling analysis
• Dose-response laboratory evaluations

Its receptor-specific activity allows researchers to study GLP-1 mediated metabolic effects in a controlled environment.


Scientific Context

GLP-1 receptor agonists, such as Semaglutide, are widely referenced in research for their ability to modulate metabolic pathways. The compound is especially relevant for studies examining incretin-based metabolic regulation and related endocrine mechanisms.

Semaglutide is considered a benchmark GLP-1 receptor agonist in metabolic research due to its high receptor specificity and well-characterized signaling profile.


Product Specifications

Product Name: Semaglutide
Content: 2 mg per vial
Form: Lyophilized powder
Grade: Research use only
Purity: High laboratory-grade purity
Packaging: Sterile sealed glass vial
Storage: Store refrigerated at 2–8°C


Stability and Handling

The lyophilized form ensures long-term stability under appropriate laboratory storage conditions.

Recommended laboratory handling:

• Store at 2–8°C
• Protect from light and moisture
• Avoid repeated freeze–thaw cycles
• Reconstitute under sterile laboratory conditions

Proper handling preserves structural integrity and ensures reliable experimental results.


Research Classification

Semaglutide is classified as an investigational peptide compound intended exclusively for:

• In vitro laboratory research
• Analytical testing
• Scientific experimentation
• Controlled research applications

It is not approved for therapeutic, diagnostic, veterinary, or human use.


Important Notice

This product is sold strictly for laboratory research purposes only.

It is not intended for human consumption, medical use, or clinical application. By purchasing this product, the buyer confirms that it will be used solely for lawful scientific research.